Arrow and Apotex set to merge generic and OTC businesses

Deal raises hopes for fewer shortages

Arrow Pharmaceuticals and Apotex are merging their generic and OTC businesses — a deal that could help reduce medicine shortages.


One of the aims of the merger is to shore up supplies of low-cost generics to pharmacies, says Roger Millichamp, Managing Director Asia Pacific for Apotex.

“We believe the proposed merger will provide greater certainty in sourcing and providing additional supply options.

“While medicines shortages cannot be ruled out, they should be minimised as a result of the merger and enhanced processes and